Table 3.
CON RNAi | CSH RNAi | % Change | p-Value | |
---|---|---|---|---|
(n = 4) | (n = 4) | |||
Crown-rump length, cm | 49.98 ± 1.67 | 45.73 ± 2.10 | 8.50 | 0.16 |
Ponderal index | 3.19 ± 0.15 | 2.86 ± 0.24 | 10.48 | 0.28 |
Lower leg length, cm | 37.25 ± 1.16 | 32.38 ± 1.15 | 13.09 | 0.02 |
Brain, g | 47.71 ± 1.21 | 46.05 ± 3.72 | 3.48 | 0.69 |
Brain: fetal weight | 0.0121 ± 0.000 | 0.0172 ± 0.002 | 42.63 | 0.03 |
Liver, g | 100.33 ± 9.13 | 65.50 ± 15.80 | 34.71 | 0.10 |
Brain: liver | 0.45 ± 0.03 | 0.79 ± 0.21 | 73.65 | 0.17 |
Liver: fetal weight | 0.0267 ± 0.001 | 0.0247 ± 0.004 | 7.64 | 0.62 |
Left liver lobe, g | 27.19 ± 4.53 | 17.74 ± 4.07 | 34.76 | 0.17 |
Right liver lobe, g | 75.46 ± 3.24 | 47.88 ± 11.71 | 36.54 | 0.06 |
Heart, g | 22.48 ± 1.79 | 17.28 ± 2.14 | 23.15 | 0.11 |
Heart: fetal weight | 0.0056 ± 0.000 | 0.0063 ± 0.001 | 12.29 | 0.23 |
Left ventricle, g | 9.02 ± 0.81 | 6.68 ± 0.48 | 25.91 | 0.05 |
Right ventricle, g | 4.99 ± 0.32 | 3.81 ± 0.70 | 23.56 | 0.18 |
Lungs, g | 123.18 ± 8.76 | 101.61 ± 15.44 | 17.51 | 0.27 |
Lungs: fetal weight | 0.031 ± 0.001 | 0.0364 ± 0.001 | 17.31 | 0.01 |
Pancreas, g | 3.25 ± 0.33 | 2.40 ± 0.42 | 26.21 | 0.16 |
Kidneys, g | 20.05 ± 1.21 | 15.61 ± 2.33 | 22.17 | 0.14 |
Perirenal adipose tissue (PRAT), g | 13.36 ± 1.96 | 10.58 ± 1.23 | 20.80 | 0.27 |
Spleen, g | 6.48 ± 0.58 | 5.24 ± 1.24 | 19.24 | 0.40 |
Adrenal glands, g | 0.32 ± 0.02 | 0.34 ± 0.06 | 4.38 | 0.86 |
Biceps femoris (BF), g | 28.69 ± 1.22 | 17.97 ± 2.19 | 37.35 | 0.01 |
Soleus, g | 0.35 ± 0.06 | 0.14 ± 0.04 | 60.28 | 0.02 |
Flexor digitorum superficialis (FDS), g | 3.08 ± 0.27 | 1.93 ± 0.31 | 37.45 | 0.03 |
Tibialis anterior (TA), g | 3.8 ± 0.35 | 2.37 ± 0.32 | 37.59 | 0.02 |
Extensor digitorum longus (EDL), g | 1.01 ± 0.10 | 0.59 ± 0.10 | 42.22 | 0.03 |
Uteroplacental weight, g | 1829.40 ± 136.67 | 1333.65 ± 207.93 | 27.10 | 0.09 |
Membrane weight, g | 483.55 ± 32.18 | 470.28 ± 112.73 | 2.75 | 0.91 |
Total placentome, # | 67.25 ± 4.09 | 71.75 ± 10.09 | 6.69 | 0.69 |
Data are shown as means ± SEM for all pregnancies in each treatment group. CSH, chorionic somatomammotropin; RNAi, RNA interference.